Incyte (INCY) Gross Profit (QoQ) (2012 - 2026)
Powered by 
Analysis
Incyte (INCY) Gross Profit (QoQ) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.37 Bn | 130.52 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.18 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.33 Bn | 58.15 Bn | 1.37 Bn |
| 4 | Moderna | 57.92 Bn | 52.78 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.48 Bn | 32.17 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - |
| 9 | Insmed | 27.38 Bn | 26.22 Bn | 358.27 Mn |
| 10 | Incyte | 25.57 Bn | 21.03 Bn | 1.57 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 34.32% |
| Mar 31, 2026 | -15.70% |
| Dec 31, 2025 | 9.37% |
| Sep 30, 2025 | 11.45% |
| Jun 30, 2025 | 16.03% |
| Mar 31, 2025 | -10.14% |
| Dec 31, 2024 | 3.64% |
| Sep 30, 2024 | 8.76% |
| Jun 30, 2024 | 17.95% |
| Mar 31, 2024 | -13.10% |
| Dec 31, 2023 | 9.86% |
| Sep 30, 2023 | -3.09% |
| Jun 30, 2023 | 17.88% |
| Mar 31, 2023 | -13.33% |
| Dec 31, 2022 | 12.85% |
| Sep 30, 2022 | -10.69% |
| Jun 30, 2022 | 24.64% |
| Mar 31, 2022 | -15.67% |
| Dec 31, 2021 | 5.93% |
| Sep 30, 2021 | 15.79% |